A 'perverse disincentive' for hospitals that have invested in expensive technology for robotic surgery may be jeopardizing prostate cancer patients who seek out the procedure, concludes a new study.
from Robotics News & Articles http://ift.tt/1A6Ua4U
0 comments:
Post a Comment